Harvard Apparatus Regenerative Technology Completes $2.84M Private Placement

What Happened

• Harvard Apparatus Regenerative Technology, Inc. announced it closed a private placement on September 11, 2026, selling an aggregate 2,703,727 shares of common stock for total proceeds of $2,838,911 at $1.05 per share.
• CEO Jerry (Junli) He purchased 683,725 of those shares by converting and cancelling $717,911 of outstanding bridge promissory notes that had been issued to him earlier in 2026; the converted shares were issued at the same $1.05 per share price.

Key Details

• Private placement closed: September 11, 2026.
• Shares issued: 2,703,727 common shares.
• Gross proceeds: $2,838,911 (price per share $1.05).
• CEO conversion: Jerry (Junli) He converted $717,911 of notes into 683,725 shares; notes cancelled in full.
• Securities were sold in a private (unregistered) placement under applicable exemptions; Purchase Agreements contain customary representations and warranties.

Why It Matters

• The company received immediate capital of about $2.84 million, which strengthens liquidity and reduces short-term debt due to the CEO's note conversion.
• Issuing 2.7 million new shares increases the company’s outstanding share count (dilution effect for existing shareholders); the filing does not state the post‑issuance share total.
• The transaction was done via a private placement (not a registered public offering); terms and representations are standard for such deals and were included in the Purchase Agreements filed with the 8‑K.